Study Comparing Two Types of Psychotherapy for Treating Depression and Substance Abuse

Sponsor
US Department of Veterans Affairs (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT00108407
Collaborator
(none)
1
2

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether Integrated Cognitive Behavioral Therapy or Twelve Step Facilitation Therapy is most effective for treatment of dually diagnosed veterans with depressive and substance use disorders.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Integrated Cognitive Behavioral Therapy
  • Behavioral: Twelve Step Facilitation Therapy
N/A

Detailed Description

Depression is the most frequent co-occuring mental health disorder among adults with substance use disorders, and such comorbidity is often associated with poorer treatment outcomes. Although there is an urgent need for effective treatments specific for dual-diagnosis adults, few studies have been conducted to address this need.

Comparison: This study will compare substance use and depression symptoms of individuals in two different psychotherapy groups: Integrated Cognitive Behavioral Therapy and Twelve Step Facilitation Therapy. Symptoms and substance use will be compared during the active treatment phase (24 weeks) and for one year following the end of the active treatment.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Official Title:
Integrated CBT for Substance Use and Depressive Disorders
Study Start Date :
Oct 1, 2004

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

Integrated Cognitive Behavioral Therapy

Behavioral: Integrated Cognitive Behavioral Therapy

Experimental: 2

Twelve Step Facilitation Therapy

Behavioral: Twelve Step Facilitation Therapy

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Individuals diagnosed with one or more substance use disorders (alcohol, cannabis, and or stimulant abuse/dependence) and an independent co-occurring depressive disorder (major depression or dysthymia) will be included.
    Exclusion Criteria:
    • Individuals with substance induced mood disorders and individuals experiencing persistent psychotic symptoms.

    • Those with life threatening or unstable medical illness, neurological disorders, or inability to read will be excluded.

    • Individuals currently prescribed steroids, disulfiram, or long acting benzodiazepines will be excluded.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 VA San Diego Healthcare System, San Diego San Diego California United States 92161

    Sponsors and Collaborators

    • US Department of Veterans Affairs

    Investigators

    • Principal Investigator: Sandra Brown, PhD, VA San Diego Healthcare System, San Diego

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00108407
    Other Study ID Numbers:
    • MHBS-041-99Sa
    First Posted:
    Apr 15, 2005
    Last Update Posted:
    Mar 6, 2009
    Last Verified:
    Mar 1, 2009

    Study Results

    No Results Posted as of Mar 6, 2009